DEPO PROVERA susp inj 150 mg/ml ser us unique 1 ml
7680307740279
CH-30774
G03AC06
09.02.1.
1 / 3
google
Details
- Product number
- 3077402
- CPT
- -
- Packaging group
- 1 x 1 ml
- Unit
- Spritze(n)
- Composition
- medroxyprogesteroni acetas 150 mg, polysorbatum 80, macrogolum 3350, natrii chloridum, natrii hydroxidum q.s. ad pH, acidum hydrochloricum q.s. ad pH, propylis parahydroxybenzoas 0.15 mg, E 218 1.35 mg, aqua ad iniectabile ad suspensionem pro 1 ml corresp. natrium 3.42 mg.
Articles (1)
Depo-Provera 150, Injektionssuspension (150 mg/ml)
Injektionssuspension
1 x 1 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.15 MG | Substance | HBESI |
|
(N/A)
|
1.35 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.42 MG | Substance | HBESI |
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 30774
- Drug name
- Depo-Provera 150, Injektionssuspension
- Galenic form
- SUPA
- ATC Code
- G03AC06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 03/06/1964
- Authorization expiration date
- 31/12/9999
- IT number
- 09.02.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DEPO PROVERA susp inj 150 mg/ml ser us unique 1 ml
- Description (DE)
- DEPO PROVERA Inj Susp 150 mg/ml Einwegspr 1 ml
- Market launch
- 12/01/1982
- Narcotic (BTM)
- No